NASDAQ:PGEN

Precigen News Headlines

$6.36
-0.20 (-3.05 %)
(As of 06/17/2021 03:59 PM ET)
Add
Compare
Today's Range
$6.20
$6.52
50-Day Range
$6.24
$8.22
52-Week Range
$3.36
$11.10
Volume71,936 shs
Average Volume1.55 million shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.34

Precigen (NASDAQ PGEN) News Headlines Today

SourceHeadline
Insider Selling: Precigen, Inc. (NASDAQ:PGEN) Major Shareholder Sells 509,467 Shares of StockInsider Selling: Precigen, Inc. (NASDAQ:PGEN) Major Shareholder Sells 509,467 Shares of Stock
americanbankingnews.com - June 15 at 8:46 PM
Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes - Yahoo FinancePrecigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes - Yahoo Finance
finance.yahoo.com - June 13 at 10:58 PM
Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes - BenzingaPrecigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes - Benzinga
benzinga.com - June 13 at 7:57 AM
28 Stocks Moving in Fridays Pre-Market Session Gainers Amesite Inc. (NASDAQ: AMST) - Benzinga28 Stocks Moving in Friday's Pre-Market Session Gainers Amesite Inc. (NASDAQ: AMST) - Benzinga
benzinga.com - June 12 at 9:44 PM
Hot Stocks: Tesla makes Plaid sexy, big drug development moves, PLAY gets play - Seeking AlphaHot Stocks: Tesla makes Plaid sexy, big drug development moves, PLAY gets play - Seeking Alpha
seekingalpha.com - June 11 at 5:41 PM
Precigen soars 28% on positive AG019 Actobiotics data in type 1 diabetes - Seeking AlphaPrecigen soars 28% on positive AG019 Actobiotics data in type 1 diabetes - Seeking Alpha
seekingalpha.com - June 11 at 5:41 PM
Precigen Jumps as Type 1 Diabetes Treatment Progresses in Study - TheStreetPrecigen Jumps as Type 1 Diabetes Treatment Progresses in Study - TheStreet
thestreet.com - June 11 at 12:41 PM
Precigen (NASDAQ:PGEN) Shares Gap Up to $6.99Precigen (NASDAQ:PGEN) Shares Gap Up to $6.99
americanbankingnews.com - June 11 at 10:26 AM
After-Hours Stock Movers 06/10: (PGEN) (AMEH) (ARWR) Higher; (VRTX) (ELY) (SNOW) Lower (more...) - StreetInsider.comAfter-Hours Stock Movers 06/10: (PGEN) (AMEH) (ARWR) Higher; (VRTX) (ELY) (SNOW) Lower (more...) - StreetInsider.com
streetinsider.com - June 11 at 12:56 AM
Precigen Up 30% After Hours on Diabetes Drug Study Results - MarketWatchPrecigen Up 30% After Hours on Diabetes Drug Study Results - MarketWatch
marketwatch.com - June 11 at 12:56 AM
Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 DiabetesPrecigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes
finance.yahoo.com - June 10 at 7:55 PM
Precigen to Present at the JMP Securities Life Sciences Conference - Yahoo FinancePrecigen to Present at the JMP Securities Life Sciences Conference - Yahoo Finance
finance.yahoo.com - June 10 at 4:32 PM
Precigen to Present at the JMP Securities Life Sciences ConferencePrecigen to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 10 at 4:32 PM
Precigen: Return On Capital Employed InsightsPrecigen: Return On Capital Employed Insights
benzinga.com - June 9 at 12:37 PM
Trading S.A. Ares Sells 72,811 Shares of Precigen, Inc. (NASDAQ:PGEN) StockTrading S.A. Ares Sells 72,811 Shares of Precigen, Inc. (NASDAQ:PGEN) Stock
americanbankingnews.com - June 1 at 8:33 PM
Next Green Wave Releases Q1 2021 Results and Launches New Product - Yahoo Finance AustraliaNext Green Wave Releases Q1 2021 Results and Launches New Product - Yahoo Finance Australia
finance.yahoo.com - June 1 at 8:48 AM
Is It Too Late to Buy Precigen (PGEN) Stock? - Yahoo FinanceIs It Too Late to Buy Precigen (PGEN) Stock? - Yahoo Finance
finance.yahoo.com - May 25 at 1:13 PM
Precigen (NASDAQ:PGEN)  Shares Down 5.4% Precigen (NASDAQ:PGEN) Shares Down 5.4%
americanbankingnews.com - May 24 at 1:42 PM
Prometheus Biosciences extends gains as former chairman of Bausch & Lomb joins board - Seeking AlphaPrometheus Biosciences extends gains as former chairman of Bausch & Lomb joins board - Seeking Alpha
seekingalpha.com - May 18 at 12:19 PM
Fred Hassan, Former CEO of Schering-Plough and Former Chairman of Bausch & Lomb, Joins Prometheus Biosciences Board - StreetInsider.comFred Hassan, Former CEO of Schering-Plough and Former Chairman of Bausch & Lomb, Joins Prometheus Biosciences Board - StreetInsider.com
streetinsider.com - May 17 at 4:11 PM
Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates - NasdaqPrecigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - May 11 at 2:38 AM
Precigen Reports First Quarter 2021 Financial ResultsPrecigen Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 10 at 4:38 PM
Oragenics: 2 New Phase 1 Trials Should Resurrect Investor Sentiment, Driving Upside By 2022 - Seeking AlphaOragenics: 2 New Phase 1 Trials Should Resurrect Investor Sentiment, Driving Upside By 2022 - Seeking Alpha
seekingalpha.com - May 9 at 3:39 PM
Can This News Push Ocugen Ahead of Pfizer and Moderna? - NasdaqCan This News Push Ocugen Ahead of Pfizer and Moderna? - Nasdaq
nasdaq.com - May 6 at 1:17 PM
Facebook Trump ruling is step towards consistency - NasdaqFacebook Trump ruling is step towards consistency - Nasdaq
nasdaq.com - May 5 at 9:13 PM
Fox Corp. Q3 21 Earnings Conference Call At 4:30 PM ET - NasdaqFox Corp. Q3 21 Earnings Conference Call At 4:30 PM ET - Nasdaq
nasdaq.com - May 5 at 7:31 PM
Precigen Breaks Below 200-Day Moving Average - Notable for PGEN - NasdaqPrecigen Breaks Below 200-Day Moving Average - Notable for PGEN - Nasdaq
nasdaq.com - May 5 at 7:31 PM
Emerson Appoints James Turley as Chair of the Board of Directors - StreetInsider.comEmerson Appoints James Turley as Chair of the Board of Directors - StreetInsider.com
streetinsider.com - May 5 at 11:12 AM
Emerson Appoints James Turley as Chair of the Board of Directors - Business WireEmerson Appoints James Turley as Chair of the Board of Directors - Business Wire
businesswire.com - May 4 at 7:26 PM
BioSolution Designs Raises Seed Round - Yahoo FinanceBioSolution Designs Raises Seed Round - Yahoo Finance
finance.yahoo.com - May 4 at 9:23 AM
The Precigen (NASDAQ:PGEN) Share Price Is Up 128% And Shareholders Are Boasting About It - NasdaqThe Precigen (NASDAQ:PGEN) Share Price Is Up 128% And Shareholders Are Boasting About It - Nasdaq
nasdaq.com - April 30 at 6:46 PM
Precigen, Inc. (PGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo FinancePrecigen, Inc. (PGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance
finance.yahoo.com - April 28 at 1:32 PM
Precigen, Inc. (PGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleasePrecigen, Inc. (PGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - April 28 at 1:32 PM
First Week of May 21st Options Trading For Precigen (PGEN) - NasdaqFirst Week of May 21st Options Trading For Precigen (PGEN) - Nasdaq
nasdaq.com - April 9 at 1:03 PM
UPDATE: Precigen Inc. (PGEN) PT Raised to $17 at Wells Fargo After First Patient Dosing of AdenoVerse - StreetInsider.comUPDATE: Precigen Inc. (PGEN) PT Raised to $17 at Wells Fargo After First Patient Dosing of AdenoVerse - StreetInsider.com
streetinsider.com - April 8 at 2:53 PM
Helen Zabsevari - BenzingaHelen Zabsevari - Benzinga
benzinga.com - April 6 at 2:29 PM
Exclusive: Precigens CEO Breaks Down Biotechs Oncology Platforms, Technology, Differentiators - BenzingaExclusive: Precigen's CEO Breaks Down Biotech's Oncology Platforms, Technology, Differentiators - Benzinga
benzinga.com - April 6 at 2:29 PM
Precigen Inc. (PGEN) Announces Departure of Chief Financial Officer - StreetInsider.comPrecigen Inc. (PGEN) Announces Departure of Chief Financial Officer - StreetInsider.com
streetinsider.com - March 31 at 9:00 PM
Precigen Announces Departure of Chief Financial Officer - Yahoo FinancePrecigen Announces Departure of Chief Financial Officer - Yahoo Finance
finance.yahoo.com - March 30 at 5:59 PM
Precigen Announces Departure of Chief Financial OfficerPrecigen Announces Departure of Chief Financial Officer
finance.yahoo.com - March 30 at 5:59 PM
How Much Of Precigen, Inc. (NASDAQ:PGEN) Do Insiders Own? - Yahoo FinanceHow Much Of Precigen, Inc. (NASDAQ:PGEN) Do Insiders Own? - Yahoo Finance
finance.yahoo.com - March 25 at 2:48 PM
How Much Of Precigen, Inc. (NASDAQ:PGEN) Do Insiders Own?How Much Of Precigen, Inc. (NASDAQ:PGEN) Do Insiders Own?
finance.yahoo.com - March 25 at 2:03 PM
Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
finance.yahoo.com - March 23 at 10:23 AM
Precigen, Inc. (I5X.F)Precigen, Inc. (I5X.F)
sg.finance.yahoo.com - March 21 at 8:41 AM
Looking Into Precigens Return On Capital Employed - Yahoo FinanceLooking Into Precigen's Return On Capital Employed - Yahoo Finance
finance.yahoo.com - March 19 at 7:35 AM
Precigen gets FDA orphan drug designation for PRGN-2012 - Seeking AlphaPrecigen gets FDA orphan drug designation for PRGN-2012 - Seeking Alpha
seekingalpha.com - March 18 at 5:22 PM
Looking Into Precigens Return On Capital Employed - BenzingaLooking Into Precigen's Return On Capital Employed - Benzinga
benzinga.com - March 18 at 10:27 AM
Virtual Expo Preview- John McCamant - Yahoo FinanceVirtual Expo Preview- John McCamant - Yahoo Finance
finance.yahoo.com - March 12 at 9:05 PM
Global Synthetic Biology in Agriculture and Food Markets, 2020-2025: Prominent Players are BASF, Bayer, Precigen, Amyris, Gingko Bioworks, Pivot Bio, Mosa Meat, and Twist Bioscience - GlobeNewswireGlobal Synthetic Biology in Agriculture and Food Markets, 2020-2025: Prominent Players are BASF, Bayer, Precigen, Amyris, Gingko Bioworks, Pivot Bio, Mosa Meat, and Twist Bioscience - GlobeNewswire
globenewswire.com - March 12 at 11:03 AM
AavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer - StreetInsider.comAavantiBio Adds Veteran Life Sciences Executive Douglas J. Swirsky as Chief Financial Officer and Treasurer - StreetInsider.com
streetinsider.com - March 4 at 7:38 AM
This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.